NPPA notified regarding Computation of Retail Price for bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg + Sitagliptin Phosphate Monohydrate eq. to Sitagliptin 100 mg + Metformin Hydrochloride IP 1000 mg

Mar 03, 2024 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on March 01, 2024, issued the notification regarding the Computation of Retail Price

The following has been stated namely: -

• The retail price was based on February, 2023 Data under Para 5 of DPCO, 2013

• This is regarding each Film coated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg + Sitagliptin Phosphate Monohydrate eq. to Sitagliptin 100 mg + Metformin Hydrochloride IP 1000 mg (as Extended Release) for M/s Synokem Pharmaceuticals Ltd (Manufacturer) and M/s Primus Remedies Pvt Ltd (Marketer)

 

[Notification No. 19(3844)/2023/DP/NPPA/DIV.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT